Oral Solid Dosage Manufacturing Keynote Series Planned for INTERPHEX

Industry experts will discuss advanced manufacturing concepts.
Apr 17, 2018
By Pharmaceutical Technology Editors

Pharmaceutical Technology will present the INTERPHEX Keynote Series: Oral Solid Dosage Manufacturing on Tuesday, April 17, 2018. Three sessions, at 10:30 am, 11 am, and 11:30 am, will feature industry experts sharing developments in process analytical technology (PAT) and continuous manufacturing. The sessions will be held on the show floor at the Innovation Stage and are open to all show attendees.

Employing the Internet of Things and PAT for Solid Dosage Forms Manufacturing

Research underway at Innopharm Labs’ pilot facility in Dublin, Ireland, combines the concepts of Industrial Internet of Things (IoT), Industry 4.0, machine-to-machine connectivity, and the adoption of artificial intelligence. This approach uses process analytical technology tools to track and control process, laying the groundwork for real-time release and self-guided processing.  

Presenter: Ian Jones, CEO Innopharma Labs, will discuss the concepts, lessons they’ve learned so far, and challenges that remain in making the vision of advanced manufacturing a reality. 

Click here to add this 10:30–10:55 am  session to your INTERPHEX calendar or see more show information.

Click here to register for INTERPHEX.

PCMM (Portable, Continuous, Miniature, and Modular) OSD Manufacturing Facility Platform 

The PCMM Collaboration brought together the expertise of Pfizer, GlaxoSmithKline, GEA, and G-CON to collectively develop the next generation oral solid-dosage manufacturing platform to address the changing requirements of pharmaceutical manufacturing for flexible, agile, and rapidly deployable processing platforms. An overview of the PCMM program initiative will be presented, including a review of the original prototype facility design which was installed at the Pfizer Groton, CT site in 2015, as well as an update on the PCMM 2nd Generation design that was initiated in 2016 when GSK joined the PCMM consortium.  The presentation will touch on the process capability and focus mostly on the modular facility design aspect.  

Presenter: Dennis Powers, Director of Sales Engineering, G-CON Manufacturing, Inc.

Click here to add this 11–11:25 am  session to your INTERPHEX calendar or see more show information.

Click here to register for INTERPHEX.

Continuous Manufacturing Roundtable: Best Practices for Implementation  

The pharmaceutical industry has made progress in implementing continuous manufacturing for oral solid-dosage drugs. Commercial processes have been approved, and process understanding is growing. This expert panel will discuss the current capabilities, ongoing challenges, and best practices for configuring equipment, optimizing startup and changeover, handling cleaning and maintenance, and other equipment and system implementation issues.   

Moderator: Jennifer Markarian, Pharmaceutical Technology

Panel participants:   

Dave DiProspero, Associate/Director Pharmaceutical Process Technology, CRB

Doug Hausner, PhD, Associate Director for the Engineering Research Center for Structured Organic Particulate Systems (C-SOPS) based at Rutgers University 

Sharon Nowak, Global Business Development Manager, Food and Pharmaceuticals, Coperion K-Tron 

José Luis Santos, PhD, Head of Operations, Drug Product Continuous Manufacturing at Hovione 

Click here to add this 11:30 am–12:30 pm session to your INTERPHEX calendar or see more show information.

Click here to register for INTERPHEX.



lorem ipsum